Breschi, G. L., F. Demma, P. Morelli, and M. De Francesco. “Brentuximab Vedotin in Adult Patients With HL CD30+ at High Risk of Relapse or Progression Following ASCT: A Cost-Analysis in Italy”. AboutOpen, vol. 8, no. 1, Sept. 2021, pp. 81-87, doi:10.33393/ao.2021.2263.